{
    "msg": "获取章节试题成功",
    "data": {
        "test": {
            "ReturnMessage": "取数据成功",
            "APPEName": "ZY_LCZY_YTMJ",
            "GenDate": "Wed May 15 2019 02:28:54 GMT+0800 (CST)",
            "StyleItems": [
                {
                    "StyleID": 1,
                    "Style": "A1型题",
                    "Explain": "A1型题：每一道考试题下面有A、B、C、D、E五个备选答案。请从中选择一个最佳答案。",
                    "Score": 1,
                    "Type": "ATEST",
                    "SubType": "",
                    "TestCount": 5,
                    "TestItems": [
                        {
                            "Title": "8d998bc089b5f832b481a4762edfa29cc52e562abe2a3e283537b1b55fd04b76f4a5db7d914e37b8",
                            "Explain": "T3作用快而强，T4作用弱而慢。甲状腺激素在细胞核内与其受体结合，诱导靶基因转录而发挥效应。其作用有维持正常生长发育、促进代谢和产热、提高机体交感-肾上腺系统的反应性等。维持生长发育、增强心脏对儿茶酚胺的敏感性、维持神经系统功能、促进代谢。",
                            "TestPoint": "抗甲状腺药物",
                            "Answer": "C",
                            "Difficulty": "中",
                            "SelectedItems": [
                                {
                                    "HasImg": 1,
                                    "ItemName": "A",
                                    "Content": "维持生长发育"
                                },
                                {
                                    "HasImg": 0,
                                    "ItemName": "B",
                                    "Content": "增强心脏对儿茶酚胺的敏感性"
                                },
                                {
                                    "HasImg": 0,
                                    "ItemName": "C",
                                    "Content": "维持血液系统功能正常"
                                },
                                {
                                    "HasImg": 0,
                                    "ItemName": "D",
                                    "Content": "维持神经系统功能"
                                },
                                {
                                    "HasImg": 0,
                                    "ItemName": "E",
                                    "Content": "促进代谢"
                                }
                            ],
                            "StyleType": "ATEST",
                            "AllTestID": 43002739,
                            "ATestID": 43002739,
                            "SrcID": 9,
                            "SbjID": 39,
                            "CptID": 387,
                            "IsFav": 0,
                            "UserNoteContent": "",
                            "DealInfo": ""
                        },
                        {
                            "Title": "84c4227f3c12b921a51eb19b33b475d2f51bd0b17f4903750ac5cb4a71d3a32781f8913980027c3fafbb7059f8cee740816dbacbce858aa9",
                            "Explain": "T3起效快，作用强。",
                            "TestPoint": "抗甲状腺药物",
                            "Answer": "B",
                            "Difficulty": "中",
                            "SelectedItems": [
                                {
                                    "Content": "T[3.gif]的血浆蛋白结合率高于T[4.gif]",
                                    "ItemName": "A"
                                },
                                {
                                    "Content": "T[3.gif]起效快，作用强",
                                    "ItemName": "B"
                                },
                                {
                                    "Content": "T[3.gif]起效慢，作用持久",
                                    "ItemName": "C"
                                },
                                {
                                    "Content": "T[3.gif]起效快，作用持久",
                                    "ItemName": "D"
                                },
                                {
                                    "Content": "T[3.gif]起效慢，作用弱",
                                    "ItemName": "E"
                                }
                            ],
                            "StyleType": "ATEST",
                            "AllTestID": 43002740,
                            "ATestID": 43002740,
                            "SrcID": 9,
                            "SbjID": 39,
                            "CptID": 387,
                            "IsFav": 0,
                            "UserNoteContent": "",
                            "DealInfo": "经核实，该试题无误，不修改",
                            "OperateTime": "2017年8月29日"
                        },
                        {
                            "Title": "ec5b3c88a865307f3be4c1cf22a22a71e182aa51215208ad931a258b28eda61ea98ffa6eb9353e368b0af95f3f6ee87d",
                            "Explain": "碘化物甲状腺功能亢进手术前准备：先用硫脲类控制症状，再在术前2周用大剂量碘，使腺体缩小变硬，以纠正硫脲类所引起的甲状腺组织增生、变软和充血，便于进行手术。",
                            "TestPoint": "抗甲状腺药物",
                            "Answer": "A",
                            "Difficulty": "中",
                            "SelectedItems": [
                                {
                                    "HasImg": 1,
                                    "ItemName": "A",
                                    "Content": "碘化物"
                                },
                                {
                                    "HasImg": 0,
                                    "ItemName": "B",
                                    "Content": "甲基硫氧嘧啶"
                                },
                                {
                                    "HasImg": 0,
                                    "ItemName": "C",
                                    "Content": "丙基硫氧嘧啶"
                                },
                                {
                                    "HasImg": 0,
                                    "ItemName": "D",
                                    "Content": "甲巯咪唑"
                                },
                                {
                                    "HasImg": 0,
                                    "ItemName": "E",
                                    "Content": "卡比马唑"
                                }
                            ],
                            "StyleType": "ATEST",
                            "AllTestID": 43002741,
                            "ATestID": 43002741,
                            "SrcID": 9,
                            "SbjID": 39,
                            "CptID": 387,
                            "IsFav": 0,
                            "UserNoteContent": "",
                            "DealInfo": ""
                        },
                        {
                            "Title": "00f41a2dc034902dbaff9a2126a720e9c7ee4b3953123c7bb021b971cda2fe507029bc78caff527a81d7684f6a0493523fae7ac09e5bc9ab",
                            "Explain": "抗甲状腺药物治疗、辅助治疗和加强营养的生活治疗等。抗甲状腺药物以硫脲类化合物为主，此方法是内科治疗中的主要方法。辅助治疗主要是采用心得安、利血平等对症治疗。生活治疗是适当休息，饮食给予足够的营养和热量，包括糖、蛋白质、脂肪及B族维生素等，并注意避免精神刺激和过度疲劳。　药物治疗利用硫脲药物抑制甲状腺内的碘有机化，减少甲状腺激素的合成，但该类药不抑制甲状腺摄碘和已合成激素的释放。",
                            "TestPoint": "抗甲状腺药物",
                            "Answer": "A",
                            "Difficulty": "中",
                            "SelectedItems": [
                                {
                                    "HasImg": 1,
                                    "ItemName": "A",
                                    "Content": "丙基硫氧嘧啶"
                                },
                                {
                                    "HasImg": 0,
                                    "ItemName": "B",
                                    "Content": "普萘洛尔"
                                },
                                {
                                    "HasImg": 0,
                                    "ItemName": "C",
                                    "Content": "甲状腺素"
                                },
                                {
                                    "HasImg": 1,
                                    "ItemName": "D",
                                    "Content": "[~131.gif]I"
                                },
                                {
                                    "HasImg": 0,
                                    "ItemName": "E",
                                    "Content": "碘化钾"
                                }
                            ],
                            "StyleType": "ATEST",
                            "AllTestID": 43002742,
                            "ATestID": 43002742,
                            "SrcID": 9,
                            "SbjID": 39,
                            "CptID": 387,
                            "IsFav": 0,
                            "UserNoteContent": "",
                            "DealInfo": ""
                        },
                        {
                            "Title": "0a37ee1065b706923f768ab4f86bf09be50925b6cb719a3a944b58686ae70aba1113dfe2b052570c0f032146876698bebeebd56a2b810be7fa4c151bdfe71e26",
                            "Explain": "硫脲类抗甲状腺药常见的不良反应为瘙痒、药疹等过敏反应，严重的不良反应为粒细胞缺乏症。因此在用药期间应定期检查血象。故选C。",
                            "TestPoint": "",
                            "Answer": "C",
                            "Difficulty": "",
                            "SelectedItems": [
                                {
                                    "ItemName": "A",
                                    "Content": "黏液性水肿"
                                },
                                {
                                    "ItemName": "B",
                                    "Content": "心动过缓"
                                },
                                {
                                    "ItemName": "C",
                                    "Content": "粒细胞缺乏症"
                                },
                                {
                                    "ItemName": "D",
                                    "Content": "低蛋白血症"
                                },
                                {
                                    "ItemName": "E",
                                    "Content": "腹泻"
                                }
                            ],
                            "StyleType": "ATEST",
                            "AllTestID": 43015507,
                            "ATestID": 43015507,
                            "SrcID": 9,
                            "SbjID": 39,
                            "CptID": 387,
                            "IsFav": 0,
                            "UserNoteContent": "",
                            "DealInfo": ""
                        }
                    ]
                },
                {
                    "StyleID": 3,
                    "Style": "B1型题",
                    "Explain": "B1型题：以下提供若干组考题，每组考题共用在考题前列出的A、B、C、D、E五个备选答案。请从中选择一个与问题关系最密切的答案。某个备选答案可能被选择一次、多次或不被选择。",
                    "Score": 1,
                    "Type": "BTEST",
                    "SubType": "单项",
                    "TestCount": 2,
                    "TestItems": [
                        {
                            "Title": "0a37ee1065b7069221f8168a2bc7c107c3b681d8bcb00edb78e219865ff46ec2c53dbe6832e3ecf4",
                            "Explain": "该药物的不良反应主要是粒细胞减少及药疹 。粒细胞缺乏为致命性，多于初治2～3个月及复治1～2周发生 。",
                            "TestPoint": "降血糖药",
                            "Answer": "B",
                            "Difficulty": "难",
                            "StyleType": "BTEST",
                            "SubStyleType": "ATEST",
                            "FrontTitle": "",
                            "SelectedItems": [
                                {
                                    "ItemName": "A",
                                    "Content": "诱发心绞痛"
                                },
                                {
                                    "ItemName": "B",
                                    "Content": "粒细胞缺乏"
                                },
                                {
                                    "ItemName": "C",
                                    "Content": "甲状腺功能减退"
                                },
                                {
                                    "ItemName": "D",
                                    "Content": "血管神经性水肿"
                                },
                                {
                                    "ItemName": "E",
                                    "Content": "肝功能不良"
                                }
                            ],
                            "AllTestID": 43002743,
                            "BTestID": 43000711,
                            "SrcID": 9,
                            "SbjID": 39,
                            "CptID": 387,
                            "BTestItems": [
                                {
                                    "BTestItemID": 43000711,
                                    "Title": "0a37ee1065b7069221f8168a2bc7c107c3b681d8bcb00edb78e219865ff46ec2c53dbe6832e3ecf4",
                                    "Explain": "该药物的不良反应主要是粒细胞减少及药疹 。粒细胞缺乏为致命性，多于初治2～3个月及复治1～2周发生 。",
                                    "TestPoint": "降血糖药",
                                    "Answer": "B",
                                    "DealInfo": ""
                                },
                                {
                                    "BTestItemID": 43000712,
                                    "Title": "e990e96508e28c2413d656c18482c0f1bd18561d34a560d58988d5cf8bc31677773b99e545505bec",
                                    "Explain": "[~131.gif]I的主要不良反应是甲状腺功能减退。",
                                    "TestPoint": "抗甲状腺药物",
                                    "Answer": "C",
                                    "DealInfo": ""
                                }
                            ],
                            "IsFav": 0,
                            "UserNoteContent": ""
                        }
                    ]
                }
            ]
        },
        "isVip": 0,
        "testInfo": [
            {
                "AllTestID": 43002739,
                "ChildTableID": -1,
                "Correction": [],
                "Statistics": {
                    "Correction": [],
                    "Test": {
                        "AppID": 1328,
                        "AllTestID": 43002739,
                        "ChildTableID": -1,
                        "UserCount": 1418,
                        "RightCount": 932,
                        "FavCount": 42,
                        "DiscussionCount": 0,
                        "ExplainCount": 0,
                        "ConcernCount": 11
                    }
                },
                "Analysis": [],
                "KnowledgePoint": {
                    "Summary": null,
                    "KnowledgeText": null,
                    "AllTestID": 43002739,
                    "ChildTableID": -1
                },
                "DiscussionCount": 0,
                "ExplainCount": 0,
                "ConcernCount": 11
            },
            {
                "AllTestID": 43002740,
                "ChildTableID": -1,
                "Correction": [],
                "Statistics": {
                    "Correction": [],
                    "Test": {
                        "AppID": 1328,
                        "AllTestID": 43002740,
                        "ChildTableID": -1,
                        "UserCount": 1426,
                        "RightCount": 802,
                        "FavCount": 47,
                        "DiscussionCount": 0,
                        "ExplainCount": 0,
                        "ConcernCount": 23
                    }
                },
                "Analysis": [],
                "KnowledgePoint": {
                    "Summary": null,
                    "KnowledgeText": null,
                    "AllTestID": 43002740,
                    "ChildTableID": -1
                },
                "DiscussionCount": 0,
                "ExplainCount": 0,
                "ConcernCount": 23
            },
            {
                "AllTestID": 43002741,
                "ChildTableID": -1,
                "Correction": [],
                "Statistics": {
                    "Correction": [],
                    "Test": {
                        "AppID": 1328,
                        "AllTestID": 43002741,
                        "ChildTableID": -1,
                        "UserCount": 1321,
                        "RightCount": 985,
                        "FavCount": 26,
                        "DiscussionCount": 0,
                        "ExplainCount": 0,
                        "ConcernCount": 11
                    }
                },
                "Analysis": [],
                "KnowledgePoint": {
                    "Summary": null,
                    "KnowledgeText": null,
                    "AllTestID": 43002741,
                    "ChildTableID": -1
                },
                "DiscussionCount": 0,
                "ExplainCount": 0,
                "ConcernCount": 11
            },
            {
                "AllTestID": 43002742,
                "ChildTableID": -1,
                "Correction": [],
                "Statistics": {
                    "Correction": [],
                    "Test": {
                        "AppID": 1328,
                        "AllTestID": 43002742,
                        "ChildTableID": -1,
                        "UserCount": 1353,
                        "RightCount": 1012,
                        "FavCount": 22,
                        "DiscussionCount": 0,
                        "ExplainCount": 0,
                        "ConcernCount": 7
                    }
                },
                "Analysis": [],
                "KnowledgePoint": {
                    "Summary": null,
                    "KnowledgeText": null,
                    "AllTestID": 43002742,
                    "ChildTableID": -1
                },
                "DiscussionCount": 0,
                "ExplainCount": 0,
                "ConcernCount": 7
            },
            {
                "AllTestID": 43015507,
                "ChildTableID": -1,
                "Correction": [],
                "Statistics": {
                    "Correction": [],
                    "Test": {
                        "AppID": 1328,
                        "AllTestID": 43015507,
                        "ChildTableID": -1,
                        "UserCount": 1194,
                        "RightCount": 988,
                        "FavCount": 20,
                        "DiscussionCount": 0,
                        "ExplainCount": 0,
                        "ConcernCount": 7
                    }
                },
                "Analysis": [],
                "KnowledgePoint": {
                    "Summary": null,
                    "KnowledgeText": null,
                    "AllTestID": 43015507,
                    "ChildTableID": -1
                },
                "DiscussionCount": 0,
                "ExplainCount": 0,
                "ConcernCount": 7
            },
            {
                "AllTestID": 43002743,
                "ChildTableID": 43000711,
                "Correction": [],
                "Statistics": {
                    "Correction": [],
                    "Test": {
                        "AppID": 1328,
                        "AllTestID": 43002743,
                        "ChildTableID": 43000711,
                        "UserCount": 1177,
                        "RightCount": 1058,
                        "FavCount": 11,
                        "DiscussionCount": 0,
                        "ExplainCount": 0,
                        "ConcernCount": 3
                    }
                },
                "Analysis": [],
                "KnowledgePoint": {
                    "Summary": null,
                    "KnowledgeText": null,
                    "AllTestID": 43002743,
                    "ChildTableID": 43000711
                },
                "DiscussionCount": 0,
                "ExplainCount": 0,
                "ConcernCount": 3
            },
            {
                "AllTestID": 43002743,
                "ChildTableID": 43000712,
                "Correction": [],
                "Statistics": {
                    "Correction": [],
                    "Test": {
                        "AppID": 1328,
                        "AllTestID": 43002743,
                        "ChildTableID": 43000712,
                        "UserCount": 1274,
                        "RightCount": 906,
                        "FavCount": 26,
                        "DiscussionCount": 0,
                        "ExplainCount": 0,
                        "ConcernCount": 9
                    }
                },
                "Analysis": [],
                "KnowledgePoint": {
                    "Summary": null,
                    "KnowledgeText": null,
                    "AllTestID": 43002743,
                    "ChildTableID": 43000712
                },
                "DiscussionCount": 0,
                "ExplainCount": 0,
                "ConcernCount": 9
            }
        ],
        "info": [],
        "encoded": 1,
        "examHistoryID": 0,
        "yimoinfo": [],
        "UserTime": 0
    },
    "status": 200
}